{
  "ticker": "LEU",
  "content": "**Report Generated:** January 13, 2026  \n**Next Refresh:** April 14, 2026\n\n**Disclaimer:** This sell-side report was generated using Claude Sonnet 4 (claude-sonnet-4-20250514). Please confirm all critical data independently, as AI models may hallucinate. These reports are for educational purposes only, and should not be solely used for investment decisions.\n\n---\n\n# Centrus Energy Corp. (LEU) - Comprehensive Analysis Report\n\n## 1. Company Overview\n\nCentrus Energy Corp. supplies nuclear fuel components for the nuclear power industry in the United States, Belgium, Japan, the Netherlands, and internationally. Centrus Energy is a trusted American supplier of nuclear fuel and services for the nuclear power industry, helping meet the growing need for clean, affordable, carbon-free energy. Since 1998, the Company has provided its utility customers with more than 1,850 reactor years of fuel, which is equivalent to more than 7 billion tons of coal.\n\nThe company operates in two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants. The Technical Solutions segment offers technical, manufacturing, engineering, and operations services to public and private sector customers.\n\nCentrus has designed, manufactured, and successfully operated the world's most advanced gas centrifuge enrichment technology, the American Centrifuge, which has undergone rigorous testing by the Department of Energy and is available for national security deployment as well as commercial nuclear fuel production. With world-class technical and engineering capabilities, Centrus is pioneering production of High-Assay, Low-Enriched Uranium and is leading the effort to restore America's uranium enrichment capabilities at scale.\n\n## 2. Current Market Data\n\nThe Centrus Energy stock price today is 301.29. With a market cap of 5.68B, Centrus Energy(LEU) trades at $311.80. The stock has a price-to-earnings ratio of 46.54.\n\nAs of 2026-01-12, Centrus Energy(LEU) stock has fluctuated between $296.00 and $315.87. During the past year, Centrus Energy(LEU) stock moved between $49.40 at its lowest and $464.25 at its peak. The Centrus Energy 52-week high stock price is 464.25, which is 50.1% above the current share price.\n\nOver the past year, Centrus Energy stocks surged 268.24%, as per data from Benzinga Pro. On Monday, the stock jumped 10.24% to close at $300.41.\n\n## 3. Existing Products/Services\n\n**LEU Segment:**\nThe LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants. Its LEU segment supplies various components of nuclear fuel to commercial customers from its global network of suppliers. The LEU segment consists of two components: SWU and natural uranium hexafluoride.\n\n**HALEU Production:**\nCentrus Energy, in the United States, began producing HALEU from a demonstration-scale cascade in October 2023. Currently, Centrus Energy's American Centrifuge Operating is the only U.S.-owned, NRC-licensed facility to produce HALEU in the United States.\n\n**Technical Solutions:**\nThe Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. From concept to production, Centrus Technical Solutions helps our customers reduce the time, cost, and risk of developing and manufacturing complex engineered products. Centrus Technical Solutions provides a one-stop shop for meeting the advanced nuclear industry's manufacturing and fuel design needs.\n\n## 4. Planned Products/Services/Projects\n\n**Major Expansion at Piketon, Ohio:**\nCentrus Energy (NYSE: LEU) announced today that it has begun domestic centrifuge manufacturing to support commercial Low-Enriched Uranium (LEU) enrichment activities at its Piketon, Ohio, facility. Centrus plans to leverage its multi-billion-dollar uranium enrichment expansion to meet its growing backlog of U.S. and international customer contracts, and targets future commercial-scale production of High-Assay, Low-Enriched Uranium (HALEU) as well.\n\nThe new project is expected to support thousands of American jobs, including 1,000 construction jobs and 300 new operating jobs in Ohio, while retaining 150 existing jobs at the Piketon plant. The project will also provide hundreds of new direct jobs at Centrus' centrifuge manufacturing plant in Oak Ridge, Tennessee, and across a nationwide network of suppliers. The company also intends to build additional centrifuge cascades to expand its HALEU production capacity, produce LEU feed material for the HALEU cascades, produce additional quantities of LEU to serve the commercial market, and service national security needs.\n\n## 5. Growth Strategy\n\nCentrus' expansion is underpinned by public and private funding along with commercial contracts, a framework that includes: Department of Energy for both LEU production and HALEU production – which the Department has indicated could be U.S. and international customers aimed at supporting new, U.S. uranium enrichment capacity. Centrus continues to pursue additional LEU and HALEU sales opportunities.\n\nThird party investment: This represents another potential avenue to secure low cost of capital financing while maximizing capacity. There is continued, growing interest from the market to secure future enrichment offtake by investing in new enrichment capacity. Third party investment: This represents another potential avenue to secure low cost of capital financing while maximizing capacity. There is continued, growing interest from the market to secure future enrichment offtake by investing in new enrichment capacity.\n\n## 6. Current and Potential Major Clients\n\n**Korea Hydro & Nuclear Power (KHNP):**\n(NYSE American: LEU) and Korea Hydro & Nuclear Power (KHNP) announced today that they have entered into a contingent supply commitment to support construction of new uranium enrichment capacity at Centrus' American Centrifuge Plant in Piketon, Ohio. The purchase commitment from KHNP covers a decade of deliveries of Low-Enriched Uranium (LEU) to help fuel Korea's large fleet of reactors. Centrus has now secured a total of $1.8 billion in contingent sales commitments to date, including KHNP and, as previously disclosed, other customers, to support deployment of new capacity.\n\n**Advanced Reactor Developers:**\nSubsequent to signing the contract with the Department of Energy in 2019, to build the HALEU demonstration plant, Centrus signed a series of agreements with advanced reactor developers including TerraPower, X-Energy, and Oklo, to support the availability of HALEU.\n\n**Utility Customers:**\nCustomer contracts: Centrus has secured $2.3 billion in contracts and commitments from U.S. and international customers aimed at supporting new, U.S. uranium enrichment capacity. The company has already secured $2.3 billion in LEU purchase commitments from utilities – including both domestic customers as well as export customers – contingent upon securing the necessary financing to build the new capacity.\n\n## 7. Financial Data & Performance\n\n**Q3 2025 Results:**\nCentrus generated total revenue of $74.9 million and $57.7 million for the three months ended September 30, 2025 and 2024, respectively, an increase of $17.2 million (or 30%).\n\nNet Income: Achieved $3.9 million, a significant turnaround from a net loss of $5.0 million in the same quarter last year. Earnings Per Share (EPS): Reported $0.21 (basic) and $0.19 (diluted), surpassing the estimated EPS of $0.08.\n\nCash Position: Strengthened with an unrestricted cash balance of $1.6 billion, bolstered by a $805 million convertible senior notes offering.\n\n**Backlog:**\nThe LEU backlog is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries primarily under medium and long-term contracts with fixed commitments and approximately $2.3 billion in contingent LEU sales commitments. As of September 30, 2025, the company backlog stood at $3.9 billion, extending to 2040.\n\n## 8. Market Shares\n\n**HALEU Market Position:**\nHALEU is not yet widely available commercially. At present only Russia and China have the infrastructure to produce HALEU at scale. At present only Russia and China have the infrastructure to produce HALEU at scale. Commercial supply of HALEU is only available from Russian company Tenex.\n\nDominant U.S. HALEU Supplier: Centrus holds a unique position as the only domestic HALEU producer. That supports high‑margin DOE contracts and puts the company at the center of emerging SMR and advanced reactor programs.\n\nCentrus Energy is the only U.S. company licensed to produce next-gen nuclear fuel (HALEU), positioning it for significant future growth. Centrus Energy stands as the only American uranium enrichment company, uniquely positioned in a global market where capacity is almost entirely controlled by Russia and China.\n\n## 9. Comparison to Competitors\n\nCentrus operates in the global nuclear fuel supply industry alongside big names like Urenco, Cameco, and Orano. It stands out as the only US‑owned, US‑technology HALEU provider – a capability that is critical for small modular reactors (SMRs) and other advanced reactor designs now in development.\n\nCompetitive and Geopolitical Risks: Centrus is currently the only US HALEU provider, but international competitors like Urenco, Orano, and Cameco may accelerate their own capacity expansions.\n\nHowever, Centrus Energy is uniquely positioned to drive the next phase of nuclear innovation through HALEU production. Given these factors, Centrus Energy is the more appealing option at the moment.\n\n## 10. Partnerships, Mergers and Acquisitions\n\n**Korea Partnership:**\nBETHESDA, Md., Aug. 25, 2025 /PRNewswire/ -- Centrus Energy (NYSE American: LEU) today signed a Memorandum of Understanding (MOU) with Korea Hydro & Nuclear Power (KHNP) and POSCO International to explore potential investment to support expansion of Centrus' uranium enrichment plant in Piketon, Ohio. U.S. Secretary of Commerce Howard Lutnick and Korea's Minister of Trade, Industry and Energy Kim Jung-kwan attended the signing of the agreement, which is aimed at deepening U.S.-Korea cooperation on civilian nuclear energy. Centrus and KHNP also agreed to an increase in the supply volume of enriched uranium under the contract they signed in February 2025.\n\nNo recent major M&A activity reported in search results.\n\n## 11. Recent Developments\n\n**$2.7 Billion DOE Contract Award (January 2026):**\nYesterday, the Department of Energy announced that three enrichment services companies have been awarded task orders worth $900 million each. Those task orders were given to American Centrifuge Operating (a Centrus Energy subsidiary) and General Matter, both of which will develop domestic HALEU enrichment capacity, along with Orano Federal Services, which will build domestic LEU enrichment capacity. Three companies have been selected for significant awards, with each peaking at nearly $900 million. Centrus Energy has notably secured $900 million to back the expansion of its current 900 kg-per-year HALEU production capacity and to advance next-generation reactor fuel development.\n\n**Commercial LEU Manufacturing Launch (December 2025):**\nCentrus Energy (NYSE: LEU) announced today that it has begun domestic centrifuge manufacturing to support commercial Low-Enriched Uranium (LEU) enrichment activities at its Piketon, Ohio, facility. \"We are excited to announce the official commencement of our industrial-scale centrifuge manufacturing build for commercial LEU enrichment,\" said ... Amir Vexler.\n\n**NYSE Uplisting (December 2025):**\nCentrus Energy (NYSE: LEU) announced approval to uplist from NYSE American to the New York Stock Exchange. Trading on NYSE American will cease after market close on December 3, 2025, and shares will commence trading on the NYSE at the open on December 4\n\n## 12. AI Investment Rating & Fair Value Assessment\n\n**Investment Rating: 8.5/10**\n\n**Rationale:**\n- **Unique Market Position**: Centrus Energy is the only U.S. company licensed to produce next-gen nuclear fuel (HALEU), positioning it for significant future growth. Currently, Centrus Energy's American Centrifuge Operating is the only U.S.-owned, NRC-licensed facility to produce HALEU in the United States. Dominant U.S. HALEU Supplier: Centrus holds a unique position as the only domestic HALEU producer.\n\n- **Strong Government Support**: The Department of Energy (DOE) has allocated $2.7 billion contracts for uranium enrichment and the recipients include Centrus Energy (NYSE: LEU), which was awarded a substantial sum for its expansion plans. Centrus Energy has notably secured $900 million to back the expansion of its current 900 kg-per-year HALEU production capacity and to advance next-generation reactor fuel development.\n\n- **Robust Financial Position**: Cash Position: Strengthened with an unrestricted cash balance of $1.6 billion, bolstered by a $805 million convertible senior notes offering. As of September 30, 2025, the company backlog stood at $3.9 billion, extending to 2040.\n\n- **Growth Prospects**: Dataintelo expects the global HALEU fuel market to expand at a CAGR of 21.9% from 2025 to 2033, as more utilities construct advanced reactors and small modular reactors (SMRs). Therefore, Centrus' growth could accelerate after 2027 as its HALEU business expands.\n\n**Risk Factors:**\n- **High Valuation**: At $286 per share with a market cap of $5.2 billion, it's already trading at 72 times this year's earnings and 11 times this year's sales.\n- **Execution Risk**: Expansion plans dependent on securing continued government funding and meeting operational milestones\n- **Geopolitical Dependence**: Current reliance on Russian uranium supplies through 2027\n\n**Estimated Fair Value: $275-325**\n\nBased on the company's unique position as the sole U.S. HALEU producer, strong government backing, robust financial position, and significant growth prospects in the expanding nuclear energy market, the stock appears fairly valued at current levels around $300. The recent DOE contract award provides substantial validation and funding security, supporting the premium valuation despite high multiples.",
  "generated_date": "2026-01-13T17:37:46.351634",
  "next_refresh_date": "2026-04-14T17:37:46.351634",
  "model": "claude-sonnet-4-20250514",
  "cost": 0.3521436,
  "tokens": {
    "input": 183,
    "output": 4557,
    "cache_creation": 63376,
    "cache_read": 151932
  }
}